NCT04545502
Recruiting
Not Applicable
A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
Vascutek Ltd.31 sites in 7 countries2,000 target enrollmentFebruary 17, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Aneurysm
- Sponsor
- Vascutek Ltd.
- Enrollment
- 2000
- Locations
- 31
- Primary Endpoint
- Operative Death
- Status
- Recruiting
- Last Updated
- 11 months ago
Overview
Brief Summary
The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice.
Data will be collected both retrospectively and prospectively.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients must meet all of the following inclusion criteria in order to be eligible for inclusion in the study:
- •All Patients:
- •Patient meets the minimum age as per local regulations at time of consent
- •Patient requires treatment with study device(s) according to the IFU(s)
- •Patient is willing and able to comply with all SOC procedures and study visits
- •Patient or their legally authorised representative (LAR) has given written informed consent to participate in study, including consent to collect data retrospectively
- •For prospective emergency patients, retrospective consent is permissible
- •For retrospective patients who are deceased at time of enrollment, local EC regulations relating to consent process should be followed.
- •Retrospective Patients only:
- •Patient has a minimum of 1 year post-operative follow-up data available, or complete data to death.
Exclusion Criteria
- •Any patient who meets any of the following exclusion criteria will be excluded from participation in the study:
- •Patient is unable or unwilling to comply with the SOC procedures or follow-up regime
- •Patient is contraindicated per the device IFU
- •Patient has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving this treatment and the procedures and evaluations pre- and post-procedure
Outcomes
Primary Outcomes
Operative Death
Time Frame: 1 Year
30 Day or In-Hospital Mortality
Graft Leakage
Time Frame: 1 Year
Device Failure: The presence of leakage or excessive bleeding through graft/patch
Secondary Outcomes
- Procedural Endpoints(1 Year)
- Safety Endpoints(1 Year)
- Device Endpoints(1 Year)
Study Sites (31)
Loading locations...
Similar Trials
Enrolling By Invitation
Not Applicable
Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress IncontinenceStress Urinary IncontinenceNCT06743620Cook MyoSite96
Terminated
Not Applicable
Post Market Observational, Prospective, Multi-center StudyEmphysemaNCT01806636Boston Scientific Corporation1,275
Completed
Not Applicable
Cera™ VSD Occluder Post Market Clinical Follow-upVentricular Septal DefectNCT05939713Cardiac Children's Foundation Taiwan152
Terminated
Not Applicable
Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data CollectionCerebral AneurysmNCT02281721Stryker Neurovascular150
Active, not recruiting
Not Applicable
Prospective Case Registry for WoundsWound Healing DelayedNCT05898698Kerecis Ltd.300